Mdm2 targets the p53 transcription cofactor JMY for degradation

EMBO Reports

Volumn 8, Issue 1, 2007, Pages 84-90

  Coutts, Amanda S ^a   Boulahbel, Houda ^a   Graham, Anne ^a   La Thangue, Nicholas B ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDM2; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR JMY; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; TRANSCRIPTION REGULATION; UBIQUITINATION;

ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; DNA DAMAGE; HUMANS; MICE; NUCLEAR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN;

EID: 33846030177     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7400855     Document Type: Article

References (26)

1. Alarcon-Vargas D, Ronai Z (2002) p53-Mdm2 - the affair that never ends. Carcinogenesis 23: 541-547
2. Ardley HC, Robinson PA (2005) E3 ubiquitin ligases. Essays Biochem 41: 15-30
3. Ashcroft M, Taya Y, Vousden KH (2000) Stress signals utilize multiple pathways to stabilize p53. Mol Cell Biol 20: 3224-3233
4. Barak Y, Juven T, Haffner R, Oren M (1993) mdm2 expression is induced by wild type p53 activity. EMBO J 12: 461-468
5. Boyd SD, Tsai KY, Jacks T (2000) An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat Cell Biol 2: 563-568
6. Chan HM, La Thangue NB (2001) p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 114: 2363-2373
7. Chen J, Wu X, Lin J, Levine AJ (1996) mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol Cell Biol 16: 2445-2452
8. Coutts AS, La Thangue NB (2005) The p53 response: Emerging levels of co-factor complexity. Biochem Biophys Res Commun 331: 778-785
9. Demonacos C, Krstic-Demonacos M, La Thangue NB (2001) A TPR motif cofactor contributes to p300 activity in the p53 response. Mol Cell 8: 71-84
10. Demonacos C, Krstic-Demonacos M, Smith L, Xu D, O'Connor DP, Jansson M, La Thangue NB (2004) A new effector pathway links ATM kinase with the DNA damage response. Nat Cell Biol 6: 968-976
11. Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM (2000) Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 275: 8945-8951
12. Freedman DA, Wu L, Levine AJ (1999) Functions of the MDM2 oncoprotein. Cell Mol Life Sci 55: 96-107
13. Geyer RK, Yu ZK, Maki CG (2000) The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat Cell Biol 2: 569-573
14. Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao ZX, Kumar S, Howley PM, Livingston DM (1998) p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell 2: 405-415
15. Grossman SR, Deato ME, Brignone C, Chan HM, Kung AL, Tagami H, Nakatani Y, Livingston DM (2003) Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300: 342-344
16. Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299
17. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R, Harris CC (1994) Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22: 3551-3555
18. Kubbutat MH, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303
19. Kubbutat MH, Ludwig RL, Levine AJ, Vousden KH (1999) Analysis of the degradation function of Mdm2. Cell Growth Differ 10: 87-92
20. Lai Z et al (2002) Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors. Proc Natl Acad Sci USA 99: 14734-14739
21. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331
22. Lohrum MA, Woods DB, Ludwig RL, Balint E, Vousden KH (2001) C-terminal ubiquitination of p53 contributes to nuclear export. Mol Cell Biol 21: 8521-8532
23. Shikama N, Lee CW, France S, Delavaine L, Lyon J, Krstic-Demonacos M, La Thangue NB (1999) A novel cofactor for p300 that regulates the p53 response. Mol Cell 4: 365-376
24. Vassilev LT et al (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303: 844-848
25. Vousden KH, Lu X (2002) Live or let die: The cell's response to p53. Nat Rev Cancer 2: 594-604
26. Zhu Q, Yao J, Wani G, Wani MA, Wani AA (2001) Mdm2 mutant defective in binding p300 promotes ubiquitination but not degradation of p53: evidence for the role of p300 in integrating ubiquitination and proteolysis. J Biol Chem 276: 29695-29701